BROWN BROTHERS HARRIMAN & CO – Sarepta Therapeutics, Inc. Transaction History
BROWN BROTHERS HARRIMAN & CO portfolio value:
$1.14M
portfolio value
BROWN BROTHERS HARRIMAN & CO quarter portfolio value change:
+47.47%
quarter
Sarepta Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | 369K | $110.54 | 10.37K | |
Q2 2022 | share | 0.00% | 0 shares | -33K | $74.96 | 10.37K | |
Q1 2022 | share | 0.00% | 0 shares | -124K | $78.12 | 10.37K | |
Q4 2021 | share | 0.00% | 0 shares | -25K | $90.59 | 10.37K | |
Q3 2021 | share | 0.00% | 0 shares | 153K | $92.48 | 10.37K | |
Q2 2021 | share | 0.00% | 0 shares | 33K | $77.74 | 10.37K | |
Q1 2021 | share | 0.00% | 0 shares | -995K | $74.53 | 10.37K | |
Q4 2020 | share | 0.00% | 0 shares | 312K | $170.49 | 10.37K | |
Q3 2020 | share | 0.00% | 0 shares | -207K | $140.43 | 10.37K | |
Q2 2020 | share | Decrease | -22.44% | -3K shares | 355K | $160.34 | 10.37K |
Q1 2020 | share | 0.00% | 0 shares | -417K | $97.82 | 13.37K | |
Q4 2019 | share | Decrease | -0.02% | -3 shares | 718K | $129.04 | 13.37K |
Q3 2019 | share | Decrease | -0.04% | -5 shares | -1.02M | $75.32 | 13.37K |
Q2 2019 | share | Increase | +0.06% | 8 shares | 439K | $151.95 | 13.37K |
Q1 2019 | share | 0.00% | 0 shares | 135K | $119.19 | 13.37K | |
Q4 2018 | share | 0.00% | 0 shares | -700K | $109.13 | 13.37K | |
Q3 2018 | share | Decrease | -47.30% | -12K shares | -1.19M | $161.51 | 13.37K |
Q2 2018 | share | 0.00% | 0 shares | 1.47M | $132.18 | 25.37K | |
Q1 2018 | share | Decrease | -10.57% | -3K shares | 301K | $74.09 | 25.37K |
Q4 2017 | share | Decrease | -9.56% | -3K shares | 156K | $55.64 | 28.37K |
Q3 2017 | share | 0.00% | 0 shares | 366K | $45.36 | 31.37K | |
Q2 2017 | share | 0.00% | 0 shares | 128K | $33.71 | 31.37K | |
Q1 2017 | share | 0.00% | 0 shares | 69K | $29.6 | 31.37K | |
Q4 2016 | share | 0.00% | 0 shares | -1.06M | $27.43 | 31.37K | |
Q3 2016 | share | Decrease | -1.97% | -630 shares | 1.31M | $61.41 | 31.37K |
Q2 2016 | share | 0.00% | 0 shares | -15K | $19.07 | 32K | |
Q1 2016 | share | 0.00% | 0 shares | -610K | $19.52 | 32K |